Newcastle disease virus vaccine encapsulated in biodegradable nanoparticles for mucosal delivery of a human vaccine

An overwhelming number of medicines on the market are oral medicine with the disadvantage of lower bioavailability universally. Newcastle disease (ND) has become a serious disease that threatens the poultry industries in many countries, and there are no treatments available for ND. The biodegradable materials could be surface modified and protect antigen or DNA from damage. Furthermore, nanoparticles are also a potential drug delivery with proper size. However, Newcastle disease virus (NDV) vaccines encapsulated in nanoparticles were widely used due to their proved a high safety and induced quicker and better mucosal and humoral immune responses. Here we review the results of mucosal immune delivery system for ND. Due to the safety, low toxicity, and better immunogenicity of the mucosal immune delivery system, our studies provide a clearly view that used the biodegradable materials to research and develop the human vaccines to save more patients’ lives. These promising results provide a foundation for testing the approach in humans.

[1]  Zheng Jin,et al.  Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in chitosan nanoparticles , 2014, International journal of nanomedicine.

[2]  Marlus Chorilli,et al.  Nanotechnology-based drug delivery systems and herbal medicines: a review , 2013, International journal of nanomedicine.

[3]  G. Chirico,et al.  Gold nanostars for superficial diseases: a promising tool for localized hyperthermia? , 2014, Nanomedicine.

[4]  Wei Li,et al.  Preparation and Efficacy of Newcastle Disease Virus DNA Vaccine Encapsulated in PLGA Nanoparticles , 2013, PloS one.

[5]  Guangcheng Yang,et al.  A novel preparation method for drug nanocrystals and characterization by ultrasonic spray-assisted electrostatic adsorption , 2013, International journal of nanomedicine.

[6]  E. Wang,et al.  Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine. , 2013, Vaccine.

[7]  A. Potter,et al.  Carrier molecules for use in veterinary vaccines. , 2013, Vaccine.

[8]  Wei Li,et al.  Preparation and Efficacy of a Live Newcastle Disease Virus Vaccine Encapsulated in Chitosan Nanoparticles , 2012, PloS one.

[9]  Kai Zhao,et al.  Preparation and immunological effectiveness of a swine influenza DNA vaccine encapsulated in chitosan nanoparticles. , 2011, Vaccine.

[10]  S. Prakash,et al.  A novel method for synthesizing PEGylated chitosan nanoparticles: strategy, preparation, and in vitro analysis , 2011, International journal of nanomedicine.

[11]  A. Ozkul,et al.  Chitosan based delivery systems for mucosal immunization against bovine herpesvirus 1 (BHV-1). , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[12]  Yi-you Huang,et al.  The influence of liposomal adjuvant on intranasal vaccination of chickens against Newcastle disease. , 2010, Veterinary journal.

[13]  M. Mel,et al.  Production of Newcastle Disease Virus by Vero Cells Grown on Cytodex 1 Microcarriers in a 2-Litre Stirred Tank Bioreactor , 2010, Journal of biomedicine & biotechnology.

[14]  B. Lambrecht,et al.  The positive adjuvant effect of chitosan on antigen-specific cell-mediated immunity after chickens vaccination with live Newcastle disease vaccine. , 2010, Veterinary immunology and immunopathology.

[15]  Yi-you Huang,et al.  Evaluation of encapsulated Newcastle disease virus liposomes using various phospholipids administered to improve chicken humoral immunity. , 2009, Journal of biomedical materials research. Part B, Applied biomaterials.

[16]  W. Jiskoot,et al.  Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[17]  Aliasger K Salem,et al.  Formulating poly(lactide-co-glycolide) particles for plasmid DNA delivery. , 2008, Journal of pharmaceutical sciences.

[18]  L. Mattoso,et al.  Preparation of chitosan nanoparticles using methacrylic acid. , 2008, Journal of colloid and interface science.

[19]  E. Carrillo,et al.  Locally produced mucosal IgG in chickens immunized with conventional vaccines for Newcastle disease virus. , 2008, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[20]  Jagdish Singh,et al.  Preparation, characterization, cytotoxicity and transfection efficiency of poly(DL-lactide-co-glycolide) and poly(DL-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA. , 2007, International journal of pharmaceutics.

[21]  R. Kinget,et al.  Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives. , 2005, Advanced drug delivery reviews.

[22]  A. Omar,et al.  Improved protection from velogenic Newcastle disease virus challenge following multiple immunizations with plasmid DNA encoding for F and HN genes. , 2005, Veterinary immunology and immunopathology.

[23]  R. Mumper,et al.  Chitosan-based nanoparticles for topical genetic immunization. , 2001, Journal of controlled release : official journal of the Controlled Release Society.